To evaluate the potential effects of si-lncARSR plus ADM on tumor growth, we subcutaneously injected U2OS/ADM cells to BALB/c nude mice to generate ADM-resistant osteosarcoma mouse models. The gene discussed is LNCARSR; the disease is neoplasm.